CIK 0001513525 · Non-accelerated filer<br>Smaller reporting company
Azora Therapeutics, Inc. (DE)
Sign in to watch- Ticker
- AZR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 800667150
- Phone
- 434-422-9800
- Business address
- 16501 VENTURA BLVD, SUITE 400, ENCINO, CA, 91436
- Former names
- ADIAL PHARMACEUTICALS, INC., Adial Pharmaceuticals, L.L.C., ADial Pharmaceuticals, L.L.C.
- S-8 Other Securities Offered to Employees in Benefit Plans
- DEF 14A Proxy Proxy Statement
- 8-K Event Delisting notice
- 8-K Event Delisting notice
- PRE 14A Proxy Proxy Statement (Preliminary)
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- 8-K Event Executive or director change · Shareholder vote results
- 10-Q/A Report 10-Q/A
- 8-K/A Event Acquisition or sale completed
- NT 10-Q/A Other NT 10-Q/A
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Material agreement · Unregistered share sale · Other events
- 4 Open-market buy Director bought 700 shares at $2.74 ($1,918)
- ARS Other Annual Report to Security Holders
Page 10 of 30 · 581 filings